Table 5.
Second‐line treatment after first‐line TACE
| All stages | Early stages | Advanced stages | P | |
|---|---|---|---|---|
| (N = 4283) | (N = 2940) | (N = 1343) | ||
| TACE | 44.2% | 38.4% | 56.9% | <0.001 |
| RFA | 22.9% | 28.2% | 11.4% | <0.001 |
| Hepatectomy | 4.0% | 4.1% | 3.7% | 0.613 |
| TAE | 2.3% | 2.3% | 2.2% | 0.825 |
| PEI | 2.1% | 2.4% | 1.4% | 0.029 |
| HAIC | 0.7% | 0.2% | 1.6% | <0.001 |
The differences in mean values between early and advanced stages were assessed and P‐values were calculated using Fisher's exact test. TACE, transcatheter arterial chemoembolization; RFA, radiofrequency ablation; TAE, transcatheter arterial embolization; PEI, percutaneous ethanol injection; HAIC, hepatic arterial infusion chemotherapy.